A single-chain antibody fragment against human thyroglobulin: construction and evaluation of immunoreactivity.

Smaller recombinant antibody fragments are at the forefront of in vivo diagnosis and therapy. These units possess better distribution and faster clearance than larger molecules. Among these, single chain antibody fragments (scFv) are emerging as credible alternatives.